Kaizaki-Mitsumoto, A; Noguchi, N; Yamaguchi, S; Odanaka, Y; Matsubayashi, S; Kumamoto, H; Fukuhara, K; Funada, M; Wada, K; Numazawa, S. Three 25-NBOMe-type drugs, three other phenethylamine-type drugs (25I-NBMD, RH34, and escaline), eight cathinone derivatives, and a phencyclidine analog MMXE, newly identified in ingredients of drug products before they were sold on the drug market Forensic Toxicol., 1 Jan 2016, 34 (1), 108–114. 854 kB. https://doi.org/10.1007/s11419-015-0293-6 #14 MS,NMR
EMCDDA. New drugs in Europe, 2015, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2016. 1.0 MB. #82
4′-Methyl-α-(pyrrolidin-1-yl)butanophenone · MPBP
4′-Methyl-α-(pyrrolidin-1-yl)isobutanophenone
O-2387 · α-(Pyrrolidin-1-yl)valerophenone · α-PVP
PPBO · α-(Piperidin-1-yl)butanophenone · α-PipBP
2,4-DMPPP · 2′,4′-Dimethyl-α-(pyrrolidin-1-yl)propanophenone
3-MPBP · 3′-Methyl-α-(pyrrolidin-1-yl)butanophenone
3,4-Trimethylenepentedrone
2-Keto-PCPr · 2′-Oxo-PCPr
N-(Cyclopropylmethyl)mephedrone · N-Cyclopropylmethyl-N-methyl-4-methylcathinone
3-Methyl-PPPO · 3′-Methyl-α-(piperidin-1-yl)propanophenone
N-Cyclopentyl-3-methylcathinone
α-(Pyrrolidin-1-yl)isovalerophenone · α-PiVP
3-Me-2′-oxo-PCE · 3D-MXE · DMXE · Deoxymethoxetamine